Related Experiment Video
Updated: Aug 25, 2025

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies
Jing Wang1,2, Zhijie Luo3, Lizhu Lin3
1State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.
Abstract:
Tumor metastasis occurs in lung cancer, resulting in tumor progression and therapy failure. Anoikis is a mechanism of apoptosis that combats tumor metastasis; it inhibits the escape of tumor cells from the native extracellular matrix to other organs. Deciphering the regulators and mechanisms of anoikis in cancer metastasis is urgently needed to treat lung cancer. Several natural and synthetic products exhibit the pro-anoikis potential in lung cancer cells and in vivo models. These products include artonin E, imperatorin, oroxylin A, lupalbigenin, sulforaphane, renieramycin M, avicequinone B, and carbenoxolone. This review summarizes the current understanding of the molecular mechanisms of anoikis regulation and relevant regulators involved in lung cancer metastasis and discusses the therapeutic potential of targeting anoikis in the treatment of lung cancer metastasis.
Insights
Anoikis, a form of apoptosis, prevents lung cancer metastasis by anchoring cells to the extracellular matrix. Targeting anoikis regulators offers a promising therapeutic strategy for treating lung cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Lung cancer metastasis is a primary cause of treatment failure.
- Anoikis, a programmed cell death, is crucial in preventing cancer cell dissemination.
- Understanding anoikis regulation is vital for developing effective lung cancer therapies.
Purpose of the Study:
- To review the molecular mechanisms regulating anoikis in lung cancer metastasis.
- To identify key regulators of anoikis involved in lung cancer progression.
- To discuss the therapeutic potential of targeting anoikis for lung cancer treatment.
Main Methods:
- Literature review of studies on anoikis and lung cancer metastasis.
- Analysis of molecular mechanisms underlying anoikis regulation.
- Summary of natural and synthetic compounds with pro-anoikis activity.
Main Results:
- Anoikis effectively inhibits tumor cell escape from the extracellular matrix, thus combating metastasis.
- Several natural products (e.g., artonin E, sulforaphane) and synthetic compounds show pro-anoikis potential.
- Specific molecular regulators and pathways governing anoikis in lung cancer have been identified.
Conclusions:
- Targeting anoikis represents a viable therapeutic strategy to combat lung cancer metastasis.
- Further research into anoikis mechanisms can lead to novel anti-metastatic drugs.
- Modulating anoikis holds significant promise for improving lung cancer patient outcomes.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

